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Abstract 
The global market for medical technologies is concentrated in the most advanced countries of the world, namely the 
U.S.A., Europe and Japan. China is the most important of fast-growing markets. According to some estimates China's 
global share in 2030 will be as much as 25%. The aim of the article is to provide an overview of the development of 
selected economic indicators of medical devices in the regions of the U.S.A., Europe and China. We address the last 
decade and comment on the estimated future development of these markets. The article is based on selective literature 
research. Indicators of the market value, global market share, market trends, and export and import values in the three 
world regions are the key elements of the analysis. We found that U.S. holds about 40%, the market value (170 billion 
USD) and Europe holds currently about 30% of the global market (110 billion USD). The Medtech market in China is 
about 10% of global one (53,6 billion USD). The U.S. market growth is about 10%, the European 5% and China market 
shows far largest growth rate about 20–25% per year. According China will become one of the major player in the 
Medtech market. The Chinese market, which has focused on low-cost production in the past, is currently coming to the 
forefront thanks to its development of high-end medical device technology. 
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Introduction 
The global market for medical technologies (Medtech) 
is concentrated. About 80% of all purchases are realized 
in the most advanced countries of the world, namely the 
U.S.A., Europe and Japan. China (along with India) can 
be ranked among the most important fast-growing 
markets. China's market share, which was only 3% in 
2012, representing 1.4% of the country's GDP, is 
continually growing at a rapid pace. According to some 
estimates China's share in 2030 will be as much as 25%. 
Rising expenditure in the healthcare sector, increasing 
demand for healthcare, and the overall better awareness 
in the area of healthcare services are all the possible 
factors that support the development of the Chinese 
medical device market [1]. 
Medical technologies, which are one of the driving 
forces behind the increase in expenditure, have a signifi-
cant impact on the overall expenditure of the healthcare 
system [2]. 
The specific characteristics of the global production 
and market are summarized by numerous studies [2–11] 
and include the high research and development costs 
and/or heavy market regulation as well as growing 
expectations of healthcare consumers. 
The aim of the article is to provide an overview of the 
development of selected economic indicators of medical 
devices in the regions of the U.S.A., Europe and China in 
the last decade and to comment on the estimated 
development of these markets based on selective 
literature research. 
Data and methods 
Like other related articles [3], this study is based on 
selective literature research which aims to describe the 
selected characteristics of the Medtech market in selected 
regions of the world. The work is based on publicly 
available data sources and does not utilize a large amount 
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of commercial data from marketing and consulting firms, 
as it is available only for high fees. Temporally, the study 
aims to cover the period of the last decade with a focus 
on the latest data sources that can be used as the basis for 
reaching partial conclusions about possible trends in the 
Medtech market in the medium term. In the study, the 
individual markets are ranked according to their current 
global market share. The article uses the method for the 
international comparison of healthcare systems, in 
particular the "side-by-side comparison" method, using 
comparable indicators for the individual monitored 
regions, in particular the global market for medical 
devices. It is thus a descriptive sectoral analysis that of 
characteristics of the markets of selected world regions 
[4]. 
For the purpose of the article, reviewed sources 
obtained using the Web of Science and Scopus databases 
(status December 2018) are used in particular, and the 
article was created within the principles of the PRISMA 
method [5]; however, this method is not applied in its 
entirety as part of the review. The criteria allow the 
inclusion of articles on the economic assessment of the 
medical device market within the timeframe of the past 
ten years, and articles on medical devices that include 
a prediction of the future market are also taken into 
consideration. Other criteria used include the focus of 
articles on market value, global market share, market 
trends, and export-import, and all of these criteria are 
applied to the topic of medical devices. 
In this publication, a comparison of the selected 
economic indicators for the individual regions described 
is presented. These indicators include: market value, i.e. 
a definition of the market in financial units (in USD 
billion; for China, some data are available only in CNY, 
for which an approximate conversion to USD is carried 
out); the percentage share of the individual regions of the 
global medical device market; market trends, i.e. 
a description of the nature of the market in the time-frame 
of the study; last but not least, exports and imports, which 
are expressed in USD billion. 
First the data for the global market is introduced, then 
the data for the individual regions of the U.S.A., Europe 
and China, followed by a side-by-side comparison, and 
finally discussions and conclusions. 
For the purpose of this work, pharmaceuticals are not 
taking into consideration. 
Global medical  device market 
The medical device market development is closely 
linked to the development of healthcare sector in general. 
The global demand for healthcare services is growing, 
and it is not very sensitive to price changes [6], which 
allows manufacturers of medical devices to increase the 
price of their technologies over time. However, in the 
study the price changes vary over time with different 
technologies. They do not show homo-geneous growth 
with tendencies to decrease in sime segments. Overall, 
the global demand for medical devices is rising steadily 
[7, 8], as Medtech play a key role in the healthcare system 
and the value of the overall global Medtech market is 
constantly increasing [9]. The proportional represen-
tation of individual types of Medtech in the overall 
product portfolio is thus changing. For example, the 
global market for diagnostic Medtech grew by 20% 
between 2016 and 2017 [10]. 
The data comparison that represents the global market 
is shown in Table 1. 
Table 1: Values of the global medical device market. 
Year of data collection 
and Source  
Size of medical device 
market (in billion USD) 
2015 [11] 2014: 340 
 
2015 [12] 2015: 228 
2018: 440 
 
2016 [13] 2016: 339 
2017: 360 
2018: 386 
2019: 412 
 
2018 [14] 2018: 440 
The growth in the global market in 2018 was about 
4.4% [15]. However, the growth in the market by region 
varies significantly around the world. The medical device 
market has long been dominated by the US, which is the 
largest producer, distributor and consumer of these 
technologies. The US currently occupies over 40% of the 
Medtech market, followed by Europe, which holds 
approximately 30% of the Medtech market, and Japan, 
with a market share of approximately 15% [12, 16]. 
China, which is moving from the position of lagger to that 
of major market opportunity and thus entering the 
forefront of interest with annual market growth of more 
than 20%. Available studies confirm, China is an 
important destination in terms of market opportunity 
[12, 17]. 
In the prediction for 2020, the studies estimate that the 
size of the global market will be in the approximate range 
of USD 435 to 483 billion [13, 18, 19]. For the year 2030, 
it will be as much as USD 795 billion [18], with the future 
ranking of the individual countries as actors in the 
Medtech market differing significantly from the present 
ranking. On-going healthcare reform and increased 
demand for healthcare in India and China are the reasons 
for this change in the structure of shares in the global 
market [17, 20]. 
In the global market, there is a relatively small number 
of large companies with a dominant position and there 
are a large number of small and medium-sized enterprises 
[7]. Johnson & Johnson dominates among Medtech 
producers according to the available studies, other 
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important players are Siemens Health, General Electric, 
Medtronics, Baxter International an Philips Healthcare  
[12, 23]. The profit margin of large companies producing 
Medtech is typically 20–30% [7]. Literature shows that 
a number of large transactions involving medical device 
companies in recent years were generally motivated by 
the desire to pursue higher growth, either through product 
portfolio acquisitions or divestments [24]. 
 
Fig. 1: Top 7 Markets for Medical Devices—Prediction 
for 2030 [18, 21, 22]. 
U.S. medical device market 
The available data show that the US medical device 
companies currently hold the largest market share, (i.e. 
about 40–45% [8, 13]), and the size of the market is 
constantly increasing. In the US, there are approxi-
mately 7,000 companies in the Medtech market, which 
directly employ 400,000 people and indirectly employ 
more than 2 million people [12, 20]. 
Selected economic indicators of the market in the US 
are in table 2. 
Investment in medical device research and develop-
ment nearly doubled in the US from 2007 to the present, 
and the same trend can be expected in the future [13]. 
Total U.S. Medical & Health R&D spending for 2015 
amounted to USD 158.7 billion, and the year-on-year 
change represented an increase of 4.5% [25]. Compared 
to other sectors (e.g. the automotive industry, defence, or 
telecommunications), investments in research and devel-
opment in the area were the highest. The level of research 
and development for 2017 was at around 7% of total 
revenue [16]. 
According to the statistics of US and European Patent 
Offices, the US was the region with the highest number 
of patents granted for medical devices between 2006 and 
2016 [26]. European patent applications filed in 2016 for 
medical devices (41%) came mostly from Europe (5,023 
submissions), while 38% were from the US. The U.S. 
medical market is globally renowned for its high level of 
research and development [27]. 
International trade plays a very significant role in the 
Medtech market in the US, as 35–40% of domestic 
production is destined for export [7]. The export value is 
USD 43–45 billion [13]. The percentage share of imports 
is similar - foreign sales represent 40–50% of the total 
revenues [7]. In relation to Canada, U.S. companies 
benefit from the similarities between the U.S. and 
Canadian regulatory platforms and quality require-ments 
for Medtech [19]. In terms of the structure of American 
exports, the category “Surgical and Medical Instruments” 
is the largest. 
With regards to imports, it should be noted that the 
volume of imported devices is constantly increasing. 
Low-tech products represent the largest proportion of 
imports [13]. For potential importers of Medtech to the 
US, the strongest competitors are domestic competitors, 
followed by producers from Canada, China and Europe 
[28]. In terms of the import structure, Surgical Appli-
ances and Supplies1 and Electro-Medical Apparatuses 
have the largest representation2 [13]. According to the 
Department of Commerce (DOC), the value of exports 
from the U.S. in 2017 was more than USD 41 billion [16]. 
Neurology is the fastest growing area of devices (9.1% 
year-on-year increase till 2024), diagnostic imaging and 
orthopedics are predicted as the ones with the lowest 
increase (3.7%) [29]. 
Key players in the market in USA are in Table 3.
Table 2: Selected economic indicators of the market in the US. 
                                                 
1 339113 – according to NAICS 
2 334510 – according to NAICA 
Year of data 
collection and 
Source 
Medical Device 
Market values 
(in USD billion) 
Annual 
increase 
Export (bil. $) Import (bil. $) Number of 
employees 
2015 [12] 2014: 125.4 
 
6.1% n/a n/a 400 000 
2016 [13] 2015: 140 
 
n/a 45 54 356 000 
2017 [28] 2016: 147.7 n/a n/a n/a n/a 
2019: 173 
 
n/a n/a n/a n/a 
2017 [16] 2017: 156 n/a 41 n/a 500 000 
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Table 3: Key players in the market in USA (in USD billion). 
Company Production Sales or Revenues (in USD billion) 
Johnson & Johnson 
 
Advanced surgical systems and instru-
ments, Endocutter technologies, bio-
surgery  
2014: 28.7 [12] 
2015: 27.5 [7] 
2017: 26.6 [23, 30] 
2018: 27.3 [31] 
 
General Electric 
 
Imaging systems (MRI, CT, X-ray, etc), 
Ultrasound systems, Life Care Solutions 
(Clinical monitoring and Acute Care 
Systems, and Complementary Software 
and services) 
2014: 18.1 [12] 
2015: 18.3 [7] 
2017:19.1 [23, 30] 
2018: 19.7 [31] 
 
 
Baxter International 
 
Healthcare products - acute and chronic 
dialysis therapies; sterile intravenous (IV) 
solutions; Infusion systems and devices; 
Inhaled anesthetics; Surgical hemostat 
and sealant products 
 
2014: 16.4 [12] 
2015: 16.7 [7] 
2017: 10.6 [23, 30] 
2018: 11.0 [31] 
 
Stryker Corp. 
 
Bed frames, Emergency patient trans-
port, Navigation systems, Orthopedic 
disposables, Surgical visualization, Tem-
perature management 
2014: n/a 
2015: 9.7 [7] 
2017: 12.4 [23, 30] 
2018: 13.3 [31] 
 
Becton Dickinson & Co. Surgical instruments, Molecular diag-
nostics, Microbiology solutions, Infusion 
Therapy, Anesthesia delivery  
2014: n/a 
2015: 12.3 [7] 
2017: 12.1 [23, 30] 
2018: 15.9 [31] 
Table 4: Selected economic indicators of the market in Europe. 
Year of data 
collection 
and Source 
Size of 
medical 
device 
market (in 
USD billion) 
HealthCare 
expenditure 
Medtech market 
- Annual 
increase 
Export Import Number of 
employees 
2015 [33] 100 6.7% 4.0% 39% USA 63% USA 575 000 
11% China 10% China 
8% Japan 6% Japan 
2015 [3] 100 4% n/a n/a n/a 575 000 
2016 [35] 110 6.5% 4.6% 37% USA 58.9% USA 650 000 
10.3% China 10.2% China 
8.1% Japan 6.2% Japan 
2018 [8] 110 6.5% 4.4% 36.9% USA 55% USA 675000 
10% China 10% China 
5.4% Japan 5% Japan 
2018 [34] 110 n/a n/a n/a n/a 675 000 
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European medical device market 
The Europe represents currently approximately 30% 
of the global market, and thus far it represents the second 
most important region for Medtech. The value of the 
European market currently represents around USD  
130–143 billion (EUR 100–110 billion). Year-on-year 
growth of the market in the period between 2006 and 
2016 averages at 4.5% [8, 32]. In Europe, an average of 
10.4% of the gross domestic product (GDP) is invested 
in healthcare. Of that, approximately 6.8% is invested in 
medical devices. However, the expenditure varies con-
siderably among countries, namely between 5 and 10% 
of their total healthcare expenditure. For Europe in 
2014, it was found that the expenditure on medical 
technology, which includes medical devices along with 
in-vitro devices, was EUR 195 per person and increased 
to EUR 203 in 2017. The value determined for the US 
was USD 380 [8, 33]. 
In Europe in 2018, there are approximately 27,000 
small and medium-sized companies manufacturing 
medical devices, employing 675,000 people [7, 34]. The 
number of employees per capita in the medical tech-
nology industry is highest in Ireland and Switzerland, 
according to a survey from 2016 [8]. Analysis of the 
reports of the European Patent Office show that  
patent applications for medical technologies represented 
approximately 7.7% of the total for all industries in 2016 
[26]. 
Table 4 shows selected economic indicators of the 
market in Europe and Table 5 below shows an overview 
of the key players in the in Europe, the focus of their 
production, their revenues and the number of employees 
in selected year. 
Table 5: Key players in the market in Europe. 
Company/Source 
  
State Production  Sales or Revenues 
(in USD/EUR billion) 
Medtronic Ireland Advanced surgical 
technology, Ablation 
products 
 
2017: 29.7 $ [30] 
2018: 30.3 $ [31] 
 
Siemens Healthcare Germany Imaging devices (MR, CT), IT 
systems, Diagnostics 
2017: 13.8 € [36] 
2017: 14.2 € [30] 
2018: 15.9 $ [31] 
 
Fresenius Germany Medtech for dialysis 2017: 17.7 € [37] 
2017: 17.8 € [30] 
2018: 19.8 $ [31] 
 
Philips Healthcare Netherlands Imaging systems (MR, CT) 
EKG, Monitoring of patients 
2017: 17.8 € [38] 
2017: 17.8 € [30] 
2018: 12.6 $ [31] 
 
Essilor  France Optical industry 2017: 7.5  €  [39] 
2018: 11.6 $ [31] 
 
Chinese medical device market 
The medical device market in China currently 
represents around 6–10% of the global market, and it has 
had a high year-on-year growth rate in the last decade 
[40]. Between 2015 and 2016, its growth was as much 
as 20%. Annual growth of 6.5–7% is expected for the 
expenditure on healthcare to 2020 [17]. This expen-
diture was at around 5% of GDP until 2010 [41]. It can 
be concluded that the main causes include the growing 
demand for healthcare, which is influenced by the higher 
age of the population and the more frequent occurrence 
of chronic diseases and age-related diseases. The overall 
increase in the demand for healthcare is also influenced 
by the increased demand for high-quality healthcare 
from rural areas [42] and for premium healthcare [43]. 
A series of healthcare reforms leading to a higher cover-
age by health insurance in the population and better 
patent protection in the area of research and develop-
ment are currently underway in China. The completion 
of these reforms has been announced for 2020 
[1, 17, 42]. 
The period leading up to 2010 was characterized by 
the fact that the companies producing Medtech mainly 
focused on mid-range products with low technology. At 
present, these producers are also able to provide high-
tech products. The "Made in China 2025" initiatives—
a plan announced in 2015—favours expanding the 
production of state-of-the-art medical devices [40]. This 
change mainly concerns therapeutic and diagnostic 
technologies [2, 20, 44]. Several years ago, the govern-
ment focused on this market and launched a number of 
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initiatives for innovation. The Office for the Evaluation 
of Innovative Medical Devices (part of the CFDA) 
provides subsidies and loans for local manufacturers to 
support research and development for diagnostic 
imaging, cardiovascular implants, IV diagnostics, etc. 
These initiatives, along with reforms of reimbursement 
processes and tendering procedures, strengthen the 
competitiveness of local producers [45]. The support for 
local producers is also grounded in the 12th Five-Year 
Plan of the Ministry of Science and Technology [40]. 
Table 6 shows a synthesis of data from professional 
publications. 
In 2009, 3000 producers who had a limited share in 
the MEDTECH market and were concentrated more on 
low-tech products were registered there [40]. In 2017, 
approximately 16,000 domestic manufacturers of medi-
cal devices and equipment, which were small and 
medium-sized enterprises, were registered there [17]. In 
2014, more than 80% of them still focused on low to 
mid-range products, but the predictions anticipate a 14% 
increase in diagnostic imaging products by 2020, a 12% 
increase in IV-diagnostics and even a 21% increase for 
orthopaedics & prosthetics production [46]. There are 
also foreign manufacturers on the market, mainly key 
global players (e.g., J&J, Philips and Siemens). More 
than 80% of Chinese medical device manufacturers are 
small to medium-sized enterprises [40]. Foreign key 
players actively expand their business in China through 
strategic actions, such as mergers and acquisitions or 
partnerships [43]. 
The largest supplier of medical devices to China is the 
US, followed by Germany and Japan. The total imports 
for 2016 amounted to USD 20.3 billion, with the US 
accounting for 32.8% (USD 6.64 billion), Germany for 
16.7% (USD 3.4 billion) and Japan for 11.8% (USD 2.3 
billion). The largest share of imports was represented by 
diagnostic medical devices - eight out of ten imported 
devices were diagnostic technologies [17, 46, 47]. 
Key players in the market in USA are in Table 7. 
 
Table 6: Selected economic indicators of the market in Chna. 
Year of data 
collection and 
Source 
Size of medical device 
market (in USD billion) 
Annual increase 
(%) 
Export 
(in USD billion) 
 
Import 
(in USD billion) 
 
2016 [41] 
 
2010: 19 2016: 23 2010: 13.8 2010: 7.33 
2017 [45] 2016: 34.5 (€) 2017–2020: 12 n/a n/a 
 
2017 [17] 
 
2014: 39.32 2017: 20.1 2014: 35.97 2014: 18.08 
2015: 47.38 2015: 38.49 2015: 18.49 
2016: 53.62 2016: 39.91 2016: 20.23 
2017: 58.63 2017: 39.39 2017: 21.34 
 
2018 [40] 2016: 53.6 n/a n/a n/a 
 
Table 7: Key players in the Medtech market in China. 
Company  Production  Sales or Revenues (in USD billion) 
Mindray patient monitoring & Life support, medical imaging 
systems 
2015: 14.49 [48] 
2017: 11.03 [49] 
 
Shinva Medical medical sterilization equipment, cleansing and disin-
fection equipment, sterile supplies, automatic conveying 
systems, process control management system, brachy-
therapy machine and others 
 
2017: 9.92 [50] 
2018: 1.56 [31] 
Wei Gao set& syringe, blood transfusion equipment, heart stent & 
intracardiac consumable, dialysis service 
2015: 9.12 [48] 
2017: 7.26 [51] 
2018: 1.14 [31] 
  
Dian Diagnostics medical diagnostic product and services (biological 
testing, pathological diagnosis, in-vitro diagnostic 
product agent distribution, and technical consulting) 
 
2017: 4.99 [52] 
Lepu Medical cardiovascular interventions, structural heart diseases, 
cardiac rhythm management 
2015: 4.27 [48] 
2017: 4.47 [53] 
2018: 0.87 [31] 
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Discussion and conclusion 
In our review we found that U.S. holds about 40%, the 
global market (170 billion USD) and the industry 
provides about 500,000 jobs. Europe holds currently 
about 30% of the global market with market value about 
110 billion USD that provides about 675,000 jobs. U.S. 
and Europe are controlling about 70% of Medtech 
market. The Medtech market in China represents about 
10% of global one. The value of the market is about 
53.6 billion USD. Market growth is about 10% in the 
US, Europe about 5% and China market show far largest 
growth rate about 20–25% per year. 
In terms of the predictions, the importance of China's 
market will grow continuously and the country will 
become one of the leading Medtech regions. China is 
recently characterized by rapid growth in production 
with high added value. As the literature suggests China 
achievements in economics are dramatic in terms of 
infrastructure as well as export among others [54] so the 
development in the field of Medtech more or less copy 
the china’s economics trends. The largest companies in 
field in China have similar revenues in comparison with 
their U.S. and European competitors. 
The "Made in China 2025" initiatives—a plan an-
nounced in 2015—favours expanding the production 
of state-of-the-art medical devices [40]. Several years 
ago, the government became involved in the market and 
launched a number of initiatives for innovation in the 
sector. The support for local producers is also grounded 
in the 12th Five-Year Plan of the China’s Ministry 
of Science and Technology. 
European countries, and developed countries else-
where, face the budgetary restrictions originated in high 
share of public funding of their health systems, which is 
often limited. 
There are limitations of this study. It references 
a heavily heterogeneous database. This does not allow 
for a complete statistical comparison of the regions and 
the impossibility of obtaining all the data for the same 
period. In addition, it is faced with different coverage of 
individual sources. This situation is basically the same 
as that in a number of other studies in the area of health 
economics. Moreover, the individual underlying studies 
often differ in terms of the financial or percentage 
representation of the individual variables studied, i.e. it 
is necessary to think in terms of interval estimates, 
which is again the standard approach. Finally, the study 
does not include major medical device markets such as 
Japan and Australia, as well as many emerging markets 
in Asia and South America. 
According to the evidence China will become one of 
the major player in the global Medtech market. China, 
which has focused on low-cost production in the past, is 
currently coming to the forefront thanks to its develop-
ment of high-end medical device technology. On the 
other hand the U.S. and European markets are also inno-
vative and will be strong competitors and are not ready 
to abandon their current global market share and 
existing dominance. 
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